Healthcare upgrades, downgrades, and initiations for Thursday

|By:, SA News Editor

Piper upgrades Forest Labs (FRX -0.2%) to Overweight from Neutral. Price target is $67.

Morgan Stanley cuts AbbVie (ABBV -3.3%) to Equalweight from Overweight.

Leerink downgrades Solta Medical (SLTM) to Market Perform from Outperform.

Stifel cuts Puma Biotechnology (PBYI -0.8%) to Hold from Buy.

Chardan starts Rockwell Medical (RMTI +3.2%) at Buy. Price target is $22.

JMP starts Chelsea Therapeutics (CHTP +5.5%) at Market Outperform. Price target is $8.